Person Communication and Meetings / Product Recall / FDA Phase / Product Issues / /
Facility
Facility Environment / No Facility / A Facility / /
IndustryTerm
behavioral health services / written electronics / process social services / opioid replacement therapy services / treatment of individuals having psychiatric disorders / /
MedicalCondition
sexually transmitted disease / syphilis / HIV / sickle cell anemia / diabetes / hepatitis B / chronic cardiopulmonary disease / psychological and social dysfunction / psychiatric disorders / opiate addiction / renal disease / hepatitis / tuberculosis / /
MedicalTreatment
Counseling / Pharmacotherapy / /
Organization
United States Drug Enforcement Administration / office of Licensure / Tennessee Board of Nursing / federal government / MINIMUM PROGRAM REQUIREMENTS FOR NON-RESIDENTIAL OPIOD TREATMENT PROGRAM FACILITIES CHAPTER / American Board of Psychiatry and Neurology / Licensure Administration / Tennessee Department of Mental Health / Rules Chapter / FDA / Non-Residential Substitution-based Treatment Center for Opiate Addiction / State Opioid Treatment Authority / Tennessee Board of Medical Examiners / Tennessee Health Services Development Agency / Tennessee Department of Commerce / United States Food and Drug Administration / Tennessee Department of Mental Health and Substance Abuse Services / Federal Substance Abuse and Mental Health Service Administration / / /
Position
Facility counselor / Psychiatrist / program physician / Director / commissioner / medical director / Executive / nurse / actively practicing physician / physician / designated program physician / advanced practice nurse / Facility program physician / licensed physician / physician assistant / legal representative / Facility physician / /
Product
Supervised / Suboxone / Subutex / Medically Supervised / Waste / States Drug / /
Minimum Program Requirements for Non-Residential Opioid Treatment Program Facilities